Education
About Us
Working with TipRanks
Follow Us
Mark Lawson Insider Profile
4 Followers
Mark Lawson, Director at Helus Pharma, holds 140.00K shares in Helus Pharma (Ticker: HELP), holds 1.53M shares in Claren Energy (Ticker: CNENF), holds 28.00K shares in Tesoro Minerals (Ticker: TSE:TES).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+130.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Lawson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Lawson
Mark Lawson's Trading History
Helus Pharma
Jan 10, 2026
Director
Uninformative Sell
―
$1.08M
Claren Energy
―
Director
―
$1.58M
Tesoro Minerals
Oct 17, 2011
President & Chief Executive Officer
Informative Buy
2.66K
C$2.52K
Genesis AI
―
Director
―
C$1.35K
WellteQ Digital Health
Sep 18, 2020
―
Uninformative Sell
30.00K
$20.40K
CoinAnalyst Corp
Sep 30, 2011
―
Informative Sell
6.05K
C$3.25K
List of latest transactions for each holding click on a transaction to see Mark Lawson's performance on stock
You May Also Like
Mark Lawson insider profile FAQ
What is the percentage of profitable transactions made by Mark Lawson?
The percentage of profitable transactions made by Mark Lawson is 50%.
What is the average return per transaction made by Mark Lawson?
The average return per transaction made by Mark Lawson is 130.10%.
What stocks does Mark Lawson hold?
Mark Lawson holds: HELP, CNENF, TSE:TES, TSE:AIG, WTEQF, TSE:COYX stocks.
What was Mark Lawson’s latest transaction?
Mark Lawson latest transaction was an Uninformative Sell of ―.
What was Mark Lawson's most profitable transaction?
Mark Lawson’s most profitable transaction was an Informative Buy of HELP stock on November 6, 2020. The return on the trade was 670.00%.
What is Mark Lawson's role in Helus Pharma?
Mark Lawson's role in Helus Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.